ipscell.com
BioTime's Cell Cure Files IND with FDA for ES cell AMD therapy - The Niche
Stem cell biotech BioTime announced the news today that its subsidiary Cell Cure Neurosciences (Cell Cure) has filed an IND with the FDA for an embryonic stem (ES) cell-based therapy for Dry age-related macular degeneration (AMD). The product to be [...]